Patent Assignment
Reel/Frame 042470/0069
Change of Name
Recorded: 2017-05-16
Pages: 3
Assignor
ZENITH EPIGENETICS CORP.
Executed: 2016-08-01
Assignee
ZENITH CAPITAL CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property
(1)
Novel Heterocyclic Compounds as Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 16, 2017
From: LIU, SHUANG; DUFFY, BRYAN CORDELL; JIANG, MAY XIAOWU; WANG, RUIFANG
To: RESVERLOGIX CORP.
Reel/Frame 042392/0968 →
Assignment of Assignor's Interest
May 16, 2017
From: RESVERLOGIX CORP.
To: RVX THERAPEUTICS INC.
Reel/Frame 042392/0981 →
Assignment of Assignor's Interest
May 16, 2017
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 042393/0029 →
General Conveyance and Assumption Agreement
May 16, 2017
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 042470/0059 →